Interferon β treatment in relapsing-remitting multiple sclerosis.: A review

被引：16

作者：

Grigoriadis, N ^{[1
]}

机构：

[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurol B, GR-54636 Thessaloniki, Greece

来源：

CLINICAL NEUROLOGY AND NEUROSURGERY | 2002年 / 104卷 / 03期

关键词：

early treatment; MRI; interferon;

D O I：

10.1016/S0303-8467(02)00048-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：251 / 258

页数：8

共 64 条

[1] Multiple sclerosis -: From probable to definite diagnosis -: A 7-year prospective study [J].

Achiron, A ;

Barak, Y .

ARCHIVES OF NEUROLOGY, 2000, 57 (07) :974-979

[2] Pharmacokinetics and pharmacodynamics of interferon beta-1a (IFN beta-1a) in healthy volunteers after intravenous, subcutaneous or intramuscular administration [J].

Alam, J ;

McAllister, A ;

Scaramucci, J ;

Jones, W ;

Rogge, M .

CLINICAL DRUG INVESTIGATION, 1997, 14 (01) :35-43

[3] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].

Barkhof, F ;

Filippi, M ;

Miller, DH ;

Scheltens, P ;

Campi, A ;

Polman, CH ;

Comi, G ;

Ader, HJ ;

Losseff, N ;

Valk, J .

BRAIN, 1997, 120 :2059-2069

[4] Magnetic resonance imaging in multiple sclerosis [J].

Clanet, M ;

Berry, I .

CURRENT OPINION IN NEUROLOGY, 1998, 11 (04) :299-303

[5] The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis [J].

Cole, SR ;

Beck, RW ;

Moke, PS ;

Kaufman, DI ;

Tourtellotte, WW .

NEUROLOGY, 1998, 51 (03) :885-887

[6] Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study [J].

De Stefano, N ;

Matthews, PM ;

Fu, LQ ;

Narayanan, S ;

Stanley, J ;

Francis, GS ;

Antel, JP ;

Arnold, DL .

BRAIN, 1998, 121 :1469-1477

[7]

DUQUETTE P, 1995, NEUROLOGY, V45, P1277

[8] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[9] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].

Ebers, GC ;

Rice, G ;

Lesaux, J ;

Paty, D ;

Oger, J ;

Li, DKB ;

Beall, S ;

Devonshire, V ;

Hashimoto, S ;

Hooge, J ;

Kastrukoff, L ;

Krieger, C ;

Mezei, M ;

Seland, P ;

Vorobeychi, G ;

Morrison, W ;

Nelson, J ;

Freedman, MS ;

Chrisie, S ;

Nelson, R ;

Rabinovitch, H ;

Freedman, C ;

Hartung, HP ;

Rieckmann, P ;

Archelos, J ;

Jung, S ;

Weilbach, F ;

Flachenecke, P ;

Sauer, J ;

Hommes, O ;

Jongen, P ;

Brouwer, S ;

McLeod, J ;

Pollard, J ;

Ng, R ;

Sandberg-Wollheim, M ;

Källén, K ;

Nilsson, P ;

Ekberg, R ;

Lundgren, A ;

Jadbäck, G ;

Wikström, J ;

Multanen, J ;

Valjakka, M ;

Carton, H ;

Lissoir, F ;

Declerq, I ;

Vieren, M ;

Peeters, E ;

Dubois, B .

LANCET, 1998, 352 (9139) :1498-1504

[10]

Esmonde TFG, 2001, NEW ENGL J MED, V344, P229

← 1 2 3 4 5 6 7 →